Scientist, Oligonucleotide Analytical Development
Denali Therapeutics
Summary
This position will carry out oligonucleotide analytical development to support our Oligonucleotide Transport Vehicle (OTV) platform. This is an exciting and unique opportunity to contribute to several programs and position us for the future as our groundbreaking OTV therapeutics enter the clinical phase.
Job description
Key Accountabilities/ Core Job Responsibilities
- Design, execute, and interpret stability-indicating chromatographic methods for ASOs/siRNA.
- Develop and apply complementary characterization techniques for ASOs/siRNA, including UV–Vis spectroscopy, mass spectrometry, NMR, Karl Fischer titration, differential scanning calorimetry (DSC), thermogravimetric analysis (TGA), and circular dichroism (CD).
- Analyze and interpret results, leveraging knowledge of oligonucleotide synthesis and purification processes to understand impurity profiles.
- Transfer analytical methods and manage activities at partner CDMOs, as needed (travel may be required).
- Author and/or review analytical data, specifications, Certificates of Analysis, and method validation protocols and reports.
- Collaborate with discovery scientists, process chemists, quality, and project teams to advance our portfolio and analytical strategies and ensure timely flow of information.
- Experience with modern artificial intelligence or machine-learning approaches to support chemistry workflows is a plus.
- Perform other responsibilities as needed.
Qualifications/Skills
- M.Sc./B.Sc. with 5+ years of relevant experience, with a record of scientific leadership and innovation as demonstrated by publications and/or patents
- Deep understanding of and demonstrated excellence in the analysis of oligonucleotides and their starting materials.
- Expertise in mass spectrometry is expected
- Knowledge of phase-appropriate QC/analytics relevant to oligonucleotide analysis
- Strong written and verbal communication skills
Requirements
- M.Sc./B.Sc. with 5+ years of relevant experience
- Record of scientific leadership and innovation as demonstrated by publications and/or patents
- Deep understanding of and demonstrated excellence in the analysis of oligonucleotides and their starting materials
- Expertise in mass spectrometry
- Knowledge of phase-appropriate QC/analytics relevant to oligonucleotide analysis
- Strong written and verbal communication skills
Company overview
Denali Therapeutics is a pioneering biotechnology company focused on developing innovative therapeutics for neurodegenerative and lysosomal storage diseases. Founded in 2015 and headquartered in South San Francisco, California, the company has developed a proprietary TransportVehicle™ (TV) platform designed to enable biotherapeutics to cross the blood-brain barrier, addressing one of the most significant challenges in treating central nervous system disorders. Denali's pipeline includes promising candidates for conditions such as Hunter syndrome (MPS II), Parkinson's disease, frontotemporal dementia, Sanfilippo syndrome (MPS IIIA), and MPS I, with several programs in advanced clinical development stages. The company collaborates with major pharmaceutical partners including Biogen and Sanofi, leveraging its platform technology to create a new class of barrier-crossing therapeutics. With approximately 500-1,000 employees and operations spanning multiple locations including Salt Lake City, Denali Therapeutics represents a leading force in neuroscience drug development, combining deep scientific expertise with a patient-centric approach to transform treatment paradigms for serious neurological conditions.